Blogs By

As pharmaceutical companies evolve toward digital-first commercial models, U.S. market access strategies seem to be lagging in the digital revolution. Companies face many...

Non-adherence to prescribed therapy can create extraordinary risks for patients. Even when provided with correct diagnoses and effective treatment plans, patients can often...

There may be no greater threat to patient outcomes than the current barriers to therapy access—especially for specialty medications.

Every day, patients need to switch to new therapies because of disease progression, side effects, affordability or other factors—and if your brand is a second- or third-, or...

It’s a problem with enormous impact for patients that has been nearly impossible to solve: Brand-eligible patients are out there, but they’ve been misdiagnosed or, even...

AI and RWD Are Hot Topics in Life Science Marketing – But Execution Lags Behind Ideation

If you’re a life science marketer, chances are you’ve been hearing about the...

Unlocking the Full Potential of Point-of-Care with Advanced Analytics

At the recent Re:Imagine Pharma Marketing virtual conference, I was excited to present on how brand...

Part Three of Our Multiple Sclerosis Series 

In our first two blog posts on challenges related to multiple sclerosis (MS) treatment, we addressed the need to build awareness...

Part Two of Our Multiple Sclerosis Series 

In our initial blog post on challenges related to multiple sclerosis (MS) treatment, we discussed the first barrier, which is...

Introducing a New Series on Multiple Sclerosis 

When it comes to multiple sclerosis (MS), there are multiple challenges that can deter patients from receiving the care they...

As the coronavirus (COVID-19) spread across the nation, greatly impacting people’s health and lives, trustworthy and relevant health information from a reliable source became...